Author
Listed:
- Kei Okatsu
(Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science
Graduate School of Frontier Sciences, The University of Tokyo)
- Toshihiko Oka
(College of Science, Rikkyo University, Toshimaku-ku)
- Masahiro Iguchi
(Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science)
- Kenji Imamura
(Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science
Graduate School of Frontier Sciences, The University of Tokyo)
- Hidetaka Kosako
(Institute for Enzyme Research, The University of Tokushima)
- Naoki Tani
(Institute for Enzyme Research, The University of Tokushima)
- Mayumi Kimura
(Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science)
- Etsu Go
(Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science)
- Fumika Koyano
(Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science
Graduate School of Frontier Sciences, The University of Tokyo)
- Manabu Funayama
(Juntendo University School of Medicine)
- Kahori Shiba-Fukushima
(Juntendo University School of Medicine)
- Shigeto Sato
(Juntendo University School of Medicine)
- Hideaki Shimizu
(RIKEN Systems and Structural Biology Center, 1-7-22 Suehiro-cho)
- Yuko Fukunaga
(Graduate School of Medical Science, Kyushu University)
- Hisaaki Taniguchi
(Institute for Enzyme Research, The University of Tokushima)
- Masaaki Komatsu
(Protein Metabolism Project, Tokyo Metropolitan Institute of Medical Science)
- Nobutaka Hattori
(Juntendo University School of Medicine)
- Katsuyoshi Mihara
(Graduate School of Medical Science, Kyushu University)
- Keiji Tanaka
(Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science)
- Noriyuki Matsuda
(Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science)
Abstract
Dysfunction of PINK1, a mitochondrial Ser/Thr kinase, causes familial Parkinson's disease (PD). Recent studies have revealed that PINK1 is rapidly degraded in healthy mitochondria but accumulates on the membrane potential (ΔΨm)-deficient mitochondria, where it recruits another familial PD gene product, Parkin, to ubiquitylate the damaged mitochondria. Despite extensive study, the mechanism underlying the homeostatic control of PINK1 remains unknown. Here we report that PINK1 is autophosphorylated following a decrease in ΔΨm and that most disease-relevant mutations hinder this event. Mass spectrometric and mutational analyses demonstrate that PINK1 autophosphorylation occurs at Ser228 and Ser402, residues that are structurally clustered together. Importantly, Ala mutation of these sites abolishes autophosphorylation of PINK1 and inhibits Parkin recruitment onto depolarized mitochondria, whereas Asp (phosphorylation-mimic) mutation promotes mitochondrial localization of Parkin even though autophosphorylation was still compromised. We propose that autophosphorylation of Ser228 and Ser402 in PINK1 is essential for efficient mitochondrial localization of Parkin.
Suggested Citation
Kei Okatsu & Toshihiko Oka & Masahiro Iguchi & Kenji Imamura & Hidetaka Kosako & Naoki Tani & Mayumi Kimura & Etsu Go & Fumika Koyano & Manabu Funayama & Kahori Shiba-Fukushima & Shigeto Sato & Hideak, 2012.
"PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria,"
Nature Communications, Nature, vol. 3(1), pages 1-10, January.
Handle:
RePEc:nat:natcom:v:3:y:2012:i:1:d:10.1038_ncomms2016
DOI: 10.1038/ncomms2016
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:3:y:2012:i:1:d:10.1038_ncomms2016. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.